BVM Medical proud sponsors of BSIR

BVM Medical’s promise for the last 33 years has been to continue to bring to customers innovative devices to improve patient outcomes.

The company says it is pleased to be corporate sponsors of BSIR again this year. “During the meeting we would like you to visit us on our stand where we will be demonstrating our CT Navigation System, Imactis.

Radiology plays a key role in the diagnosis and treatment of disease and utilises many minimally invasive procedures to achieve these goals.

Whether it is the number of controls, physician, staff and patient exposure, procedure duration or cost, many challenges face the department today.

These procedures require precision, speed and safety for all involved.

Imactis CT-Navigation is designed to assist with the daily challenges of the radiology department and can be used across a wide range of CT-guided interventions:

  • Biopsies
  • Ablations
  • Electroporation
  • Drainages
  • Osteosynthesis
  • Vertebroplasty

Sending over the CT scan in seconds users are able to plan your trajectory on both axial and sagittal views simultaneously.

Imactis –

  • Helps avoid critical structures, without angular limitations for optimal trajectory
  • Makes multi-needle alignment easier
  • Increases producibility of your intervention time
  • Has a short learning curve
  • Is an important training tool for percutaneous interventions
  • Is a portable system with a very simple set up

“The Holy Grail in CT-Guided procedures is to be able to reach any target lesion quickly and safely. Imactis CT-Navigation is a very powerful tool as it allows to plan complex trajectories and determine the entry point of the needle simultaneously,” Professor Eric de Kerviler.

This news story has been sponsored by the companies concerned and does not represent the views or opinions of RAD Magazine.  Visit our dedicated BSIR conference page to find out more.

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more